Background {#Sec1}
==========

Esophageal cancer is the sixth on the list of cancers with the highest mortality rates \[[@CR1]\]. Moreover, the increasing general life expectancy leads to a larger number of elderly patients diagnosed as esophageal cancer \[[@CR2]\]. Although esophagectomy is still positioned as the cornerstone treatment for esophageal cancer, it is associated with high morbidity and mortality rates for elderly patients despite recent advances in the surgical practice \[[@CR1], [@CR3], [@CR4]\]. Moreover, there is controversy about whether long-term outcomes after esophagectomy in elderly patients are worse compared to those in younger patients \[[@CR5], [@CR6]\].

Physiological changes with advancing age lead to a decline in physiological reserve that potentially places elderly patients at greater risks of adverse events during early postoperative courses after esophagectomy \[[@CR7]\]. Moreover, particularly in elderly patients, dysfunction of vital organs such as the heart, lungs or kidneys is associated frequently with esophageal cancer \[[@CR6], [@CR8]\]. Surgeons are typically more reluctant to perform esophagectomy for elderly patients due to the aggressiveness of surgery and high incidence of organ insufficiency.

Therefore, we aimed to compare perioperative characteristics and prognosis of elderly patients with esophageal cancer to those of non-elderly patients.

Methods {#Sec2}
=======

Ethics approval and consent to participate {#Sec3}
------------------------------------------

All procedures performed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. This study was approved by the Institutional Review Board of Nagoya University (approval number 2017--0475) and written informed consent for surgery and usage of clinical data was obtained from all participants.

Selection of patients {#Sec4}
---------------------

The study flow-chart is shown in Fig. [1](#Fig1){ref-type="fig"}. Consecutive patients (*n* = 553) underwent esophagectomy for esophageal cancer at the Nagoya University Hospital (Department of Gastroenterological Surgery) between February 2005 and March 2017. We retrieved data for 432 patients in accordance with the criteria as follows: subtotal esophagectomy with systematic 2- or 3-field lymphadenectomy; clinical T1--3 esophageal cancer according to the Union for International Cancer Control (UICC) Classification (8th Edition); and R0 resection \[[@CR9]\]. Patients who underwent planned two-stage surgery were excluded. Patients were classified into the non-elderly (age \< 75 years, *n* = 373) or elderly (age ≥ 75 years, *n* = 59) groups. We used the propensity score matching to balance in essential variables for the comparison analyses that followed. Propensity scores were estimated using a logistic regression model based on sex, neoadjuvant treatment, operative approaches (open or thoracoscopic surgery), number of field dissected, tumor size, pathological T factor, N factor and tumor nodes metastasis (TNM) stage. Two-to-one matching without replacement was performed, and the resulting score-matched pairs were used in subsequent analyses. Fig. 1Study design

Patient management {#Sec5}
------------------

The medical team cooperatively managed patients' physical condition and comorbidities before surgery. No preoperative intervention (e.g. nutritional support and rehabilitation) was routinely provided specifically for elderly patients. All patients underwent subtotal esophagectomy with systematic 2- or 3-field lymphadenectomy. This procedure comprised subtotal esophageal resection through a right thoracotomy or thoracoscopic approaches and a 2- or 3-field lymphadenectomy of nodes at the cervical, mediastinal and intra-abdominal area \[[@CR10]\]. The reconstruction method and route were determined according to the patient's condition and the surgeon's discretion. Based on evidence from the JCOG9907 study, neoadjuvant treatment is performed in patients with clinical stage II-IV esophageal cancer \[[@CR11]\]. We consider postoperative adjuvant chemotherapy (mainly fluorouracil plus cisplatin) for patients who met following criteria; i) pathological stage II-IV, ii) no neoadjuvant treatment, iii) tolerability of chemotherapy and iv) patient consent.

A routine postoperative follow-up screening including a physical, analyses of blood chemistry and tumor markers (squamous cell carcinoma \[SCC\] antigen and carcinoembryonic antigen) was provided every 3 months for the first and second year and every six months thereafter. Enhanced computed tomography (chest and abdominal cavity) once every 6 months and yearly thereafter. If the patient had a specific symptom, examinations were conducted sooner as needed.

Comparisons between groups {#Sec6}
--------------------------

Preoperative background data included demographics, performance status by the Eastern Cooperative Oncology Group classification, comorbidities, physical condition, blood test results, prognostic nutritional index (PNI = 10 × serum albumin \[g/dl\] + 0.005 × total lymphocyte count \[/mm^3^\]), and Controlling Nutritional Status (CONUT) score \[[@CR12], [@CR13]\]. The TNM Classification of Malignant Tumors, 8th Edition was used to determine pathological stage \[[@CR9]\]. A postoperative short-term outcome was evaluated based on 90-day postoperative mortality, a morbidity rate, and duration of postoperative hospitalization. We employed the Clavien-Dindo classification as a comprehensive evaluation method for postoperative complications \[[@CR14]\]. To compare long-term outcomes, disease-free and disease-specific survival as well as overall survival were analyzed.

Statistical analysis {#Sec7}
--------------------

To compare the two groups, we used a qualitative χ^2^ and quantitative Mann--Whitney's test. Survival curves were drawn using the Kaplan--Meier method. Survival differences were assessed using the Cox proportional hazards model. For all statistical analysis, JMP 13 software (SAS Institute Inc., NC, USA) was used. *P* \< 0.05 represents a statistically significant difference.

Results {#Sec8}
=======

Patients' backgrounds {#Sec9}
---------------------

Age distribution of the 432 patients was presented in Fig. [2](#Fig2){ref-type="fig"}a. The mean age was 65.8 ± 8.3 (standard deviation, SD) years, and the female:male ratio was 5.4:1. The median follow-up duration was 45.3 months. Before propensity score matching, 373 and 59 patients were classified in the non-elderly and elderly groups, respectively. As shown in Table [1](#Tab1){ref-type="table"}, there were significant differences between the non-elderly and elderly groups in neoadjuvant treatment, number of field dissected, tumor size and pathological TNM stage. After two-to-one propensity score matching, 100 and 50 patients were classified in the non-elderly and elderly groups. Neoadjuvant treatment, number of field dissected, tumor size and pathological TNM stage were balanced by propensity score matching (Table [1](#Tab1){ref-type="table"}). Fig. 2(**a**) Age distribution of patients who underwent subtotal esophagectomy. (**b**) Incidence of postoperative complications according to age Table 1Patient characteristics before and after propensity score matchingCharacteristicUnmatched comparisonMatched comparisonNon-elderly group (*n* = 373)Elderly group (*n* = 59)Standardized differenceNon-elderly group (*n* = 100)Elderly group (*n* = 50)Standardized differenceSex (male/female)314 / 5959 / 90.01684 / 1642 / 80.000Neoadjuvant treatment Not performed149 (40%)34 (58%)0.35953 (53%)29 (58%)0.101 Performed224 (60%)25 (42%)47 (47%)21 (42%)Surgical approach Open346 (93%)52 (88%)0.15889 (89%)45 (90%)0.033 Thoracoscopic27 (7%)7 (12%)11 (11%)5 (10%)Number of field dissected 2-field dissection221 (59%)49 (83%)0.52878 (78%)40 (80%)0.049 3-field dissection152 (41%)10 (17%)22 (22%)10 (20%)Tumor size (mm), mean ± SD35.4 ± 21.645.2 ± 23.6− 0.43238.3 ± 21.044.1 ± 21.6−0.212T factor pT0/pTis25 (7%)2 (3%)0.3511 (1%)00.159 pT1157 (42%)29 (49%)51 (51%)27 (54%) pT254 (14%)7 (12%)11 (11%)6 (12%) pT3129 (35%)21 (36%)37 (37%)17 (34%) pT48 (2%)000N factor pN0172 (46%)30 (51%)0.24245 (45%)25 (50%)0.183 pN1102 (27%)17 (29%)30 (30%)15 (30%) pN265 (18%)10 (17%)20 (20%)9 (18%) pN334 (9%)2 (3%)5 (5%)1 (2%)TNM stage 017 (4%)2 (3%)0.5561 (1%)00.3000 I97 (26%)23 (39%)36 (36%)21 (42%) II108 (29%)10 (17%)20 (20%)9 (18%) III103 (28%)22 (38%)36 (36%)19 (38%) IV48 (13%)2 (3%)7 (7%)1 (2%)*SD*, standard deviation

The elderly group was more likely to have significantly more overall comorbidities and cardiovascular disease (Table [2](#Tab2){ref-type="table"}). The preoperative levels of serum cholinesterase were significantly lower in the elderly group (Table [2](#Tab2){ref-type="table"}). The elderly group had significantly lower preoperative PNI values. No significant differences were found between CONUT scores (Table [2](#Tab2){ref-type="table"}). Table 2Patients' demographics and preoperative clinical characteristicsCharacteristicNon-elderly group (*n* = 100)Elderly group\
(*n* = 50)*P*Age (years), mean ± SD65.0 ± 6.977.2 ± 2.1\< 0.001Sex (male/female)84 / 1642 / 81.000Performance status (0/1)99 / 150 / 00.367Comorbidity (%) Any^a^28 (28%)23 (46%)0.030 Cardiovascular disease^a^10 (10%)12 (24%)0.026 Respiratory disease3 (3%)4 (8%)0.186 Cerebrovascular disease7 (7%)4 (8%)0.823 Renal dysfunction1 (1%)2 (4%)0.234 Diabetes mellitus11 (11%)8 (16%)0.393History of cancer (%)16 (16%)7 (14%)0.747Brinkman index ≥1000 (%)31 (31%)17 (34%)0.711Excessive alcohol consumption57 (57%)26 (52%)0.562Body mass index, mean ± SD21.0 ± 3.121.1 ± 2.80.721Blood test, median (range) Total lymphocyte count (/mm^3^)1600 (500--3400)1450 (500--2900)0.071 Albumin (g/dl)4.1 (3.0--5.0)3.9 (2.9--4.9)0.092 Cholinesterase (IU/l)276 (117--462)248 (96--369)0.015 Cholesterol (mg/dl)188 (101--360)184 (118--261)0.579 Creatinine (mg/dl)0.8 (0.2--1.6)0.9 (0.5--1.6)0.077 CEA (ng/ml)2.5 (0.4--9.5)2.5 (0.9--20.1)0.987 SCC (ng/ml)1.2 (0.3--7.9)1.3 (0.5--5.4)0.371PNI, median (range)49.5 (34.5--60.0)46.3 (35.0--57.5)0.019CONUT score, median (range)1 (0--5)1 (0--5)0.733Neoadjuvant treatment (%)47 (47%)21 (42%)0.562*SD* standard deviation, *CEA* carcinoembryonic antigen, *SCC* squamous cell carcinoma antigen, *PNI* prognostic nutritional index, *CONUT* Controlling Nutritional Status. ^a^Hypertension is not included

Intraoperative findings and pathological data {#Sec10}
---------------------------------------------

The data described in this section are shown in Table [3](#Tab3){ref-type="table"}. Surgical procedure was evenly balanced by the propensity score matching between the two groups. SCC was a dominant histopathologic type and accounted for 94 and 98% of patients in the non-elderly and elderly groups. The elderly group had marginally greater amount of intraoperative blood loss and larger frequency of intraoperative transfusion, but smaller number of dissected lymph nodes, though there were no statistically significant differences. Table 3Intraoperative and pathological characteristicsCharacteristicNon-elderly group (*n* = 100)Elderly group\
(*n* = 50)*P*Surgical approach Open89 (89%)45 (90%)0.851 Thoracoscopic11 (11%)5 (10%)Number of field dissected 2-field dissection78 (78%)40 (80%)0.777 3-field dissection22 (22%)10 (20%)Reconstruction Jejunal flap22 (22%)10 (20%)0.777 Gastric tube78 (78%)40 (80%)Operative time (minutes), mean ± SD473 ± 111475 ± 1220.889Intraoperative blood loss (ml), median (range)439 (31--1959)517 (187--1886)0.051Intraoperative transfusion (%)13 (13%)13 (26%)0.053Number of dissected lymph nodes mean ± SD43.7 ± 14.840.1 ± 15.80.097Histopathologic Type (%) Squamous cell carcinoma94490.192 Adenocarcinoma21 Others40Tumor size (mm), mean ± SD38.3 ± 21.044.1 ± 21.60.141Multiple lesion (%)15 (15%)8 (16%)0.873T factor pT0/pTis1 (1%)00.806 pT151 (51%)27 (54%) pT211 (11%)6 (12%) pT337 (37%)17 (34%) pT400N factor pN045 (45%)25 (50%)0.779 pN130 (30%)15 (30%) pN220 (20%)9 (18%) pN35 (5%)1 (2%)TNM stage 01 (1%)00.546 I36 (36%)21 (42%) II20 (20%)9 (18%) III36 (36%)19 (38%) IV7 (7%)1 (2%)SD, standard deviation

Postoperative short-term outcomes {#Sec11}
---------------------------------

Postoperative complications of at least grade 2 were experienced by 36 (36%) and 22 (44%) patients in the non-elderly and elderly groups (Table [4](#Tab4){ref-type="table"}). Moreover, 12 (12%) and 4 (8%) patients in the non-elderly and elderly groups experienced postoperative complications of at least grade 3 according to the Clavien-Dindo classification. Although incidences of postoperative pneumonia, arrhythmia and delirium were slightly increased in the elderly group (Fig. [2](#Fig2){ref-type="fig"}b), there were no significant differences in overall incidence of postoperative complications (at least grade 2), rates of repeat surgery and operative death between the two groups (Table [4](#Tab4){ref-type="table"}). The mean lengths of postoperative hospitalizations were similar between groups. The elderly group was less likely to receive postoperative adjuvant treatment (Table [4](#Tab4){ref-type="table"}). Table 4Postoperative courseCharacteristicNon-elderly group (*n* = 100)Elderly group (*n* = 50)*P*Postoperative complications (%) CD grade 2 or more36 (36%)22 (44%)0.345 CD grade 3 or more12 (12%)4 (8%)0.445Reoperation (%)6 (6%)2 (4%)0.599Operative death^a^ (%)01 (2%)0.137Length of postoperative stay (days), mean ± SD28.1 ± 20.526.0 ± 20.00.395Postoperative adjuvant therapy (%)12 (12%)1 (2%)0.022*CD* Clavien-Dindo classification, *SD* standard deviation. ^a^Death within 90 days after surgery

Long-term outcomes {#Sec12}
------------------

No significant differences were observed in the curves for disease-free and disease-specific survival of the two groups (Fig. [3](#Fig3){ref-type="fig"} a and b). Moreover, overall survival rates were comparable between the two groups (Fig. [3](#Fig3){ref-type="fig"}c). Fig. 3Prognosis of patients who underwent a curative resection for esophageal cancer according to age. (**a**) Disease-free, (**b**) disease-specific and (**c**) overall survival

Discussion {#Sec13}
==========

Here we sought to determine the outcomes of elderly patients with esophageal cancer after subtotal esophagectomy for. After adjustment by propensity score matching, we found that no significant differences were observed in overall incidence of postoperative complications, the rates of repeat surgery and death during surgery, length of postoperative hospitalization, and prognosis between the non-elderly and elderly patients.

Aging is a poor descriptor of physical, mental, or medical functional condition \[[@CR15], [@CR16]\]. Accordingly, selecting appropriate treatment in elderly patients with esophageal cancer is always challenging because impaired functional and nutritional status, comorbidities, cognitive function, quality of life after surgery, and life expectancy should be concerned \[[@CR17], [@CR18]\]. From lack of an established definition, the definitions of elderly are arbitrary and differ among studies (e.g., \> 65, \> 70, or \> 80 years). Here we defined 75 years as "elderly," because it is considered as the late-stage of elderly by Japanese society.

Our comparison here of the elderly and non-elderly groups reveal that the rate of repeat surgery, mortality and length of postoperative hospitalization, despite a slightly higher incidence of pneumonia, arrhythmia and delirium, and more frequent disadvantages including overall comorbidity, cardiovascular disease as well as impaired immune-nutritional status in the former group. These findings indicate that subtotal esophagectomy is feasible for selected elderly patients when the medical team provides an appropriate perioperative care. The possible explanations of acceptable outcomes of elderly patients are as follows: 1) The multidisciplinary medical team comprised surgeons, anesthesiologists, geriatrics physicians, physical therapist, and a nutritionist who supported patients. 2) Patients at high risk of adverse cardiopulmonary events underwent planned two-stage surgery or were subjected to different treatment. 3) Patients' postoperative complications were intensively managed to prevent exacerbation of their disease. Despite acceptable short-term outcomes, the length of hospital stay was long (mean, 28.1 and 26.0 days in the non-elderly and elderly groups). In Japan, the length of hospital stay tends to be much longer than that in the Western countries because of the difference in social and medical systems \[[@CR2], [@CR5], [@CR7], [@CR8], [@CR19]\]. Patients typically return home to daily life directly after discharge so that they stay at the hospital until they get substantial recovery, fair oral intake, and removal of all drainage tubes.

Correlations between age and prognosis of patients with esophageal cancer is a subject of debate. Diversity in definitions of elderly patients, the inclusion criteria, methods of analysis likely contribute to the discrepancy \[[@CR7], [@CR8], [@CR18]--[@CR20]\]. In the present study, long-term outcomes in the elderly group was comparable to those of the non-elderly group after adjustment of essential variables including neoadjuvant treatment, number of field dissected, tumor size and TNM stage with the propensity score matching. Further prospective studies addressing survival, cost-effectiveness, and postoperative quality of life will be required to establish treatment guidelines for elderly esophageal cancer patients.

This present study has limitations, such as a limited number of patients and potential selection biases due to the retrospective nature even after propensity score matching. In the present study, only patients who underwent subtotal esophagectomy were analyzed. Frail patients who had severe comorbidities or poor performance status were considered to be unfit for esophagectomy and subjected to different treatments. The lack of objective assessment criteria for postoperative quality of life prevented us from deepening the discussion. Unfortunately, survival data of patients undergoing palliative care that possibly support our conclusion are unavailable this time.

Conclusion {#Sec14}
==========

Short-term and long-term outcomes after subtotal esophagectomy were comparable between the elderly and non-elderly patients. Our findings indicate that subtotal esophagectomy is justified for selected elderly esophageal cancer patients and should not be withheld because of a patients' age.

CONUT

:   Controlling Nutritional Status

PNI

:   Prognostic nutritional index

SCC

:   Squamous cell carcinoma

SD

:   Standard deviation

TNM

:   Tumor nodes metastasis

UICC

:   Union for International Cancer Control

**Publisher's Note**

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

We thank Edanz Group ([www.edanzediting.com/ac](http://www.edanzediting.com/ac)) for editing a draft of this manuscript.

MK1 and YK conceived the study concept and design, analyzed data and wrote the manuscript. MK2, CT, DK and MH contributed to data acquisition and interpretation. KO contributed to statistical analysis. SY and GN revised the draft. All authors have read and approved the final version of the manuscript.

This study was not supported by any funding.

The datasets generated and analyzed during the current study are available from the corresponding author on reasonable request.

All procedures performed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later versions. This study was approved by the Institutional Review Board of Nagoya University (approval number 2017--0475) and written informed consent for surgery and usage of clinical data was obtained from all participants.

Not applicable. Individual identifying data were not included in this manuscript.

The authors declare that they have no competing interests.
